中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共129条，第1-10条 帮助

条数/页： 排序方式：
Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 4, 页码: 2884-2906
作者:  Liang, Xuewu;  Yu, Haolan;  Liang, Renwen;  Feng, Zhuanghui;  Saidahmatov, Abdusaid
  |  收藏  |  浏览/下载：16/0  |  提交时间：2024/04/09
Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells 期刊论文  OAI收割
MOLECULAR CANCER RESEARCH, 2022, 卷号: 20, 期号: 12, 页码: 1785-1798
作者:  Sun, Lin;  Wu, Qian;  Huan, Xia-Juan;  Tian, Chang-Qing;  Wang, Ying-Qing
  |  收藏  |  浏览/下载：12/0  |  提交时间：2024/03/21
Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 236, 页码: 114327
作者:  Feng, Xuexin;  Yan, Ziqin;  Zhou, Feilong;  Lou, Jianfeng;  Lyu, Xilin
  |  收藏  |  浏览/下载：16/0  |  提交时间：2024/03/21
Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文  OAI收割
CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218
作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan
  |  收藏  |  浏览/下载：54/0  |  提交时间：2021/12/16
CYH33  MYC  P300  BET  B cell lymphoma  PI3K  
Shabyar Ameliorates High Glucose Induced Retinal Pigment Epithelium Injury Through Suppressing Aldose Reductase and AMPK/mTOR/ULK1 Autophagy Pathway 期刊论文  OAI收割
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13, 期号: 5, 页码: 1-15
作者:  Liu, XY (Liu, Xiao Yan) [1] , [2] , [3];  Peng, J (Peng, Jun) [1] , [2];  He, F (He, Fei) [1];  Tursun, X (Tursun, Xirali) [4];  Li, SP (Li, Shu Ping) [1]
  |  收藏  |  浏览/下载：25/0  |  提交时间：2022/06/06
BCL-2 inhibitor synergizes with PI3K delta inhibitor and overcomes FLT3 inhibitor resistance in acute myeloid leukaemia 期刊论文  OAI收割
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 卷号: 12, 期号: 8, 页码: 3829-3842
作者:  Yao, Ming-Yue;  Wang, Ya-Fang;  Zhao, Yu;  Ling, Li-Jun;  He, Ye
  |  收藏  |  浏览/下载：20/0  |  提交时间：2022/12/13
The PROTAC selectively degrading Bcl-x(L) represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while bone 期刊论文  OAI收割
THERANOSTICS, 2022, 卷号: 12, 期号: 17, 页码: 7476-7490
作者:  Zhang, Shaoqing;  Chen, Yue;  Xu, Zhongli;  Yang, Jun;  Sun, Renhong
  |  收藏  |  浏览/下载：7/0  |  提交时间：2023/04/10
Preclinical characterization of LOXO-338, a novel, oral and selective BCL2 inhibitor. 期刊论文  OAI收割
CANCER RESEARCH, 2021, 卷号: 81, 期号: 13, 页码: 1
作者:  Brandhuber, Barbara;  Ku, Karin;  Lallena, Maria J.;  Baquero, Carmen;  Choy, Regina
  |  收藏  |  浏览/下载：36/0  |  提交时间：2021/11/04
Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start? 期刊论文  OAI收割
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 卷号: 15
作者:  Yu, Qing;  Sun, Yi
  |  收藏  |  浏览/下载：26/0  |  提交时间：2021/03/15
Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer 期刊论文  OAI收割
CANCER LETTERS, 2021, 卷号: 500
作者:  Zhang, Tao;  Wu, Bihan;  Akakuru, Ozioma Udochukwu;  Yao, Chenyang;  Sun, Shan
  |  收藏  |  浏览/下载：16/0  |  提交时间：2021/12/01